Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Sativus Tech Corp. is a former cannabis cultivation and technology-focused company that operated primarily in the cannabis cultivation, agricultural technology, and controlled-environment agriculture industries. The company focused on developing and operating large-scale indoor and hybrid cultivation facilities designed to produce pharmaceutical-grade medical cannabis, with an emphasis on data-driven cultivation methods and climate-controlled growing environments. Its primary revenue drivers historically came from the cultivation and sale of medical cannabis and the development of proprietary cultivation infrastructure.
The company was founded in the mid-2010s and was headquartered in Canada, with core operations and assets in Israel. Sativus Tech pursued a strategy of combining Canadian capital markets access with Israeli agronomic expertise and medical cannabis market exposure. In 2020, Sativus Tech completed a business combination with IM Cannabis Corp., after which Sativus ceased operating as an independent publicly traded entity, and its assets and operations were integrated into IM Cannabis. Public disclosures after this transaction increasingly reference Sativus Tech in a historical or subsidiary context rather than as a standalone operating company.
Business Operations
Prior to its merger, Sativus Tech’s core operations centered on medical cannabis cultivation through advanced indoor and greenhouse facilities. The company generated revenue through cannabis production for domestic medical markets and through supply arrangements tied to licensed distributors. Its business model emphasized high-yield, pharmaceutical-grade output supported by environmental controls, cultivation analytics, and standardized production processes.
Operationally, Sativus Tech’s primary asset was its Israeli cultivation facility, which operated under local medical cannabis regulations. The company maintained Canadian corporate operations to support capital raising, governance, and strategic oversight. Following the merger with IM Cannabis Corp., Sativus Tech’s cultivation assets became part of IM Cannabis’ broader operating segments, and independent reporting on Sativus-branded operations became limited. Data inconclusive based on available public sources regarding any continued standalone revenue generation.
Strategic Position & Investments
Sativus Tech’s strategic direction prior to its merger focused on scaling medical cannabis production, improving cultivation efficiency through technology, and positioning itself as a reliable supplier in regulated medical markets. The company pursued growth by investing in cultivation infrastructure rather than retail or consumer-facing cannabis brands, differentiating it from vertically integrated peers.
The most significant strategic transaction in the company’s history was its acquisition by IM Cannabis Corp., which represented a consolidation strategy within the international medical cannabis sector. Post-transaction, Sativus Tech’s assets contributed to IM Cannabis’ expansion in Israel and supported cross-border supply strategies. Public information regarding independent investments or new technology initiatives under the Sativus Tech name after the merger is inconclusive based on available public sources.
Geographic Footprint
Historically, Sativus Tech operated across Canada and Israel, with corporate headquarters functions based in Canada and primary cultivation activities located in Israel. The Israeli operations were central to the company’s business, given Israel’s established medical cannabis framework and research-oriented regulatory environment.
Through its integration into IM Cannabis, the geographic influence of Sativus Tech’s former assets expanded indirectly into Europe, particularly Germany, where IM Cannabis maintains distribution activities. However, Sativus Tech itself no longer reports a distinct geographic footprint, and its international presence is now embedded within its parent company’s global operations.
Leadership & Governance
Sativus Tech was founded and led by executives with backgrounds in capital markets, agriculture, and cannabis operations. Leadership emphasized operational discipline, regulatory compliance, and scalable cultivation practices. Following the merger with IM Cannabis, governance and executive oversight transitioned to the parent company, and Sativus Tech no longer maintains a separately disclosed executive team.
Key historical executives associated with Sativus Tech include:
- Barak Cohen – Founder and Chief Executive Officer
- Oren Shuster – Chairman
- David Watson – Chief Financial Officer
Leadership philosophy centered on combining institutional-grade governance with advanced cultivation expertise to meet medical cannabis standards. Current governance specific to Sativus Tech is data inconclusive based on available public sources, as executive leadership is now reported at the IM Cannabis Corp. level rather than under the Sativus Tech name.